Alzheimers, Aduhelm, FDA and Neurofeedback Studies

Our Neuropsychologists Dr. Laura Jansons, Dr. Skip Hrin, and Neurofeedback Tech legend Jay Gunkelman discuss Alzheimer's and the new Drug Aduhelm, which was recently fast-tracked by the FDA. They also discussed all the studies that show positive results for Neurofeedback that do not get the same publicity. JG" Very disappointed in the FDA" JG " The FDA has become politicized JG If all the vendors could push in the same direction things could move somewhere" Notes: Brainfutures Tomas Ros Video You can't make up a Placebo Why isn't Neurofeedback taught in Colleges Martijn Arns Have an idea for a topic or guest? [email protected]